NOGO for an Overactive Bladder (NOGO-OAB)

NCT04357223 PHASE2 UNKNOWN

This is a double-blind, randomized and placebo-controlled study to evaluate the safety and effectiveness of NoGo, a standardized extract from Angelica archangelica, on overactive bladder

Details

Lead sponsor	SagaNatura
Phase	PHASE2
Status	UNKNOWN
Enrolment	200
Start date	Fri May 01 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Mon Mar 01 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Overactive Bladder
• Nocturia

Interventions

• extract from Angelica archangelica leaf
• Placebo

Countries

Spain